Herantis Pharma appoints Dr. Charlotte Videbæk Vice President Clinical Development
Herantis Pharma Plc Company release 21 Mar 2022 at 09:00 am EET Herantis Pharma Plc (“Herantis”), an innovative biotech company developing new disease modifying therapies for Parkinson’s disease, today announced the appointment of Charlotte Videbæk, MD, as Vice President Clinical Development and member of the management team, effective 1st of April 2022. Dr. Videbæk is a board-certified neurologist from Copenhagen with a track record from international pharmaceutical companies developing therapies for neurodegenerative diseases, including Parkinson’s disease. She has worked at